• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    379.01 Up 11.77(3.20%) Feb 12, 4:00PM EST
    |After Hours : 379.09 Up 0.08 (0.02%) Feb 12, 5:04PM EST
    Prev Close:367.24
    Open:371.36
    Bid:373.49 x 400
    Ask:469.94 x 100
    1y Target Est:523.29
    Beta:1.80611
    Earnings Date:May 5 - May 9 (Est.)
    Day's Range:365.13 - 379.04
    52wk Range:350.26 - 605.93
    Volume:728,165
    Avg Vol (3m):870,436
    Market Cap:40.19B
    P/E (ttm):74.86
    EPS (ttm):5.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    REGNUp 3.20%40.19B
    AMGNUp 2.30%109.12B

    Key Statistics

    Forward P/E (1 yr):23.57
    P/S (ttm):9.29
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :12.03
    Quarterly EPS Est (Mar-16) :2.65
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):1.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback